⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29207894 | 0.97 | CA1 (0.95) | — | |
| Bromide SCHEMBL30618364 | 0.97 | CA1 (0.95) | — | |
| SCHEMBL27323608 | 0.97 | CA1 (0.95) | — | |
| Hydrochloric Acid SCHEMBL27748256 | 0.97 | CA1 (0.95) | — | |
| Hydrochloric Acid SCHEMBL30618396 | 0.97 | CA1 (0.95) | — | |
| SCHEMBL28087472 | 0.91 | CA1 (0.82) | — | |
| Dimethylamine SCHEMBL27966441 | 0.91 | CA1 (0.82) | — | |
| Acrylic Acid SCHEMBL10565138 | 0.82 | CA1 (0.67) | — | |
| SCHEMBL28307512 | 0.79 | CA1 (0.62) | — | |
| Fluorouracil SCHEMBL3410513 | 0.78 | SMN1; SMN2 (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312347-A1 | THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS | BROWN DENNIS M (US) | 2025-10-09 | — | — | US | claimed |
| CN-120054582-A | Mono-atom catalyst for denitration and sulfur resistance and preparation method thereof | 福州大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-118772067-A | Method for purifying oxaagole sodium intermediate | 金陵药业股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-12104154-B2 | Antisense oligonucleic acid | OSAKA UNIVERSITY (JP) | 2024-10-01 | — | — | US | claimed |
| US-20240294967-A1 | METHODS OF DETECTING METHYLCYTOSINE AND HYDROXYMETHYLCYTOSINE BY SEQUENCING | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-09-05 | — | — | US | claimed |
| CN-117964945-A | Zinc-based composite heat stabilizer for high-transparency PVC (polyvinyl chloride) product and preparation method thereof | 台州联成新材料有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-114814038-B | HPLC detection method for sodium Igacross bulk drug and related substances thereof | 常州制药厂有限公司 | 2023-06-13 | — | — | CN | claimed |
| WO-2023085683-A1 | HIGH-PRESSURE STORAGE CONTAINER AND MANUFACTURING METHOD THEREOF | 코오롱인더스트리 주식회사 | 2023-05-19 | — | — | WO | claimed |
| EP-0630644-A1 | ANTI-MICROBIAL AND INTERFERON-INDUCING PHARMACEUTICAL COMPOUND | LEONIDOV, Nikolai Borisovich (RU) | 1994-12-28 | — | — | EP | claimed |
| EP-0373891-B1 | Anti-tumour agents | ICI PLC (GB) | 1994-11-02 | — | — | EP | claimed |
| CN-1076693-A | 6-6-Methyl Uracil preparation method | YU HONGLIN (CN) | 1993-09-29 | — | — | CN | claimed |
| CN-1065064-A | 6-6-Methyl Uracil preparation method | YU HONGLIN (CN) | 1992-10-07 | — | — | CN | claimed |
| EP-0373891-A2 | Anti-tumour agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-06-20 | — | — | EP | claimed |
| EP-0125322-B1 | PROCESS FOR THE USE OF ERGOTROPIC AGENT COMBINATIONS IN THE BREEDING AND THE FATTENING OF USEFUL ANIMALS | VEB Berlin-Chemie (DD) | 1986-09-24 | — | — | EP | claimed |
| EP-0125322-A1 | Process for the use of ergotropic agent combinations in the breeding and the fattening of useful animals | VEB Berlin-Chemie (DD) | 1984-11-21 | — | — | EP | claimed |
| EP-0119560-A2 | Hypohalite-based bleaching, cleaning and disinfecting agent with storing stability | B. Braun-SSC AG (CH) | 1984-09-26 | — | — | EP | claimed |
| EP-0095637-A2 | Process for preparing alpha-chlorinated nitrogen heterocycles | BAYER AG (DE) | 1983-12-07 | — | — | EP | claimed |
| US-3993755-A | Pharmaceutical composition containing the N-methyl-d-glucosamine complex of 4-methyluracil and use thereof | KULBAKH VALTER OSVALDOVICH | 1976-11-23 | — | — | US | claimed |